Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers

Dow Jones07-24

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. advanced 4.8% to $229.29 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.2% to 7,408.30 and Dow Jones Industrial Average falling 1.0% to 51,711.65.

The stock's rise snapped a four-day losing streak.

Charles River Laboratories International Inc. closed 3.6% below its 52-week high of $237.86, which the company achieved on July 10th.

The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 3.4% to $291.02, Alnylam Pharmaceuticals Inc. rose 0.7% to $268.74, and Bio-Techne Corp. remained unchanged.

Trading volume totaled 1.1 million, compared to the 50-day average of 888,225.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 23, 2026 16:35 ET (20:35 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2653776829?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-24 04:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653776829","market":"sg","top_or_hot":-1,"title":"Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Charles River Laboratories International Inc. advanced 4.8% to $229.29 on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index falling 1.2% to 7,408.30 and Dow Jones Industrial Average falling 1.0% to 51,711.65. \n</p>\n<p>\n     The stock's rise snapped a four-day losing streak. \n</p>\n<p>\n     Charles River Laboratories International Inc. closed 3.6% below its 52-week high of $237.86, which the company achieved on July 10th. \n</p>\n<p>\n     The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 3.4% to $291.02, Alnylam Pharmaceuticals Inc. rose 0.7% to $268.74, and <a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> Corp. remained unchanged. \n</p>\n<p>\n     Trading volume totaled 1.1 million, compared to the 50-day average of 888,225. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2026 16:35 ET (20:35 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-24 04:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Charles River Laboratories International Inc. advanced 4.8% to $229.29 on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index falling 1.2% to 7,408.30 and Dow Jones Industrial Average falling 1.0% to 51,711.65. \n</p>\n<p>\n     The stock's rise snapped a four-day losing streak. \n</p>\n<p>\n     Charles River Laboratories International Inc. closed 3.6% below its 52-week high of $237.86, which the company achieved on July 10th. \n</p>\n<p>\n     The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 3.4% to $291.02, Alnylam Pharmaceuticals Inc. rose 0.7% to $268.74, and <a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> Corp. remained unchanged. \n</p>\n<p>\n     Trading volume totaled 1.1 million, compared to the 50-day average of 888,225. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2026 16:35 ET (20:35 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRL","symbol_name":"查尔斯河","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2653776829","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653776829","pubTimestamp":1784838900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Charles River Laboratories International Inc. advanced 4.8% to $229.29 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.2% to 7,408.30 and Dow Jones Industrial Average falling 1.0% to 51,711.65.The stock's rise snapped a four-day losing streak.Charles River Laboratories International Inc. closed 3.6% below its 52-week high of $237.86, which the company achieved on July 10th.The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 3.4% to $291.02, Alnylam Pharmaceuticals Inc. rose 0.7% to $268.74, and Bio-Techne Corp. remained unchanged.Trading volume totaled 1.1 million, compared to the 50-day average of 888,225.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 23, 2026 16:35 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRL":"查尔斯河"},"translate_title":"Charles River Laboratories International Inc. 股价上涨 4.8%，跑赢同行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1.5},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Charles River Laboratories International Inc. advanced 4.8% to $229.29 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.2% to 7,408.30 and Dow Jones Industrial Average falling 1.0% to 51,711.65. \n\n\n     The stock's rise snapped a four-day losing streak. \n\n\n     Charles River Laboratories International Inc. closed 3.6% below its 52-week high of $237.86, which the company achieved on July 10th. \n\n\n     The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 3.4% to $291.02, Alnylam Pharmaceuticals Inc. rose 0.7% to $268.74, and Bio-Techne Corp. remained unchanged. \n\n\n     Trading volume totaled 1.1 million, compared to the 50-day average of 888,225. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 23, 2026 16:35 ET (20:35 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653776829","isCrawlerRequest":true}